329 related articles for article (PubMed ID: 20818418)
1. Harnessing the complexity of DNA-damage response pathways to improve cancer treatment outcomes.
Al-Ejeh F; Kumar R; Wiegmans A; Lakhani SR; Brown MP; Khanna KK
Oncogene; 2010 Nov; 29(46):6085-98. PubMed ID: 20818418
[TBL] [Abstract][Full Text] [Related]
2. Curcumin suppresses multiple DNA damage response pathways and has potency as a sensitizer to PARP inhibitor.
Ogiwara H; Ui A; Shiotani B; Zou L; Yasui A; Kohno T
Carcinogenesis; 2013 Nov; 34(11):2486-97. PubMed ID: 23825154
[TBL] [Abstract][Full Text] [Related]
3. New opportunities in chemosensitization and radiosensitization: modulating the DNA-damage response.
Luo Y; Leverson JD
Expert Rev Anticancer Ther; 2005 Apr; 5(2):333-42. PubMed ID: 15877529
[TBL] [Abstract][Full Text] [Related]
4. The DNA damage response during mitosis.
Heijink AM; Krajewska M; van Vugt MA
Mutat Res; 2013 Oct; 750(1-2):45-55. PubMed ID: 23880065
[TBL] [Abstract][Full Text] [Related]
5. Checkpoint control and cancer.
Medema RH; Macůrek L
Oncogene; 2012 May; 31(21):2601-13. PubMed ID: 21963855
[TBL] [Abstract][Full Text] [Related]
6. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.
Smith J; Tho LM; Xu N; Gillespie DA
Adv Cancer Res; 2010; 108():73-112. PubMed ID: 21034966
[TBL] [Abstract][Full Text] [Related]
7. New insights into checkpoint kinase 1 in the DNA damage response signaling network.
Dai Y; Grant S
Clin Cancer Res; 2010 Jan; 16(2):376-83. PubMed ID: 20068082
[TBL] [Abstract][Full Text] [Related]
8. DDRI-9: a novel DNA damage response inhibitor that blocks mitotic progression.
Jun DW; Hwang M; Kim YH; Kim KT; Kim S; Lee CH
Oncotarget; 2016 Apr; 7(14):17699-710. PubMed ID: 26848527
[TBL] [Abstract][Full Text] [Related]
9. Increased cytotoxicity of an unusual DNA topoisomerase II inhibitor compound C-1305 toward HeLa cells with downregulated PARP-1 activity results from re-activation of the p53 pathway and modulation of mitotic checkpoints.
Sabisz M; Wesierska-Gadek J; Skladanowski A
Biochem Pharmacol; 2010 May; 79(10):1387-97. PubMed ID: 20067769
[TBL] [Abstract][Full Text] [Related]
10. [Cell cycle regulation after exposure to ionizing radiation].
Teyssier F; Bay JO; Dionet C; Verrelle P
Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
[TBL] [Abstract][Full Text] [Related]
11. A novel mechanism of checkpoint abrogation conferred by Chk1 downregulation.
Xiao Z; Xue J; Sowin TJ; Rosenberg SH; Zhang H
Oncogene; 2005 Feb; 24(8):1403-11. PubMed ID: 15608676
[TBL] [Abstract][Full Text] [Related]
12. DNA damage checkpoint, damage repair, and genome stability.
Liu WF; Yu SS; Chen GJ; Li YZ
Yi Chuan Xue Bao; 2006 May; 33(5):381-90. PubMed ID: 16722332
[TBL] [Abstract][Full Text] [Related]
13. Understanding DNA damage response and DNA repair pathways: applications to more targeted cancer therapeutics.
Kinsella TJ
Semin Oncol; 2009 Apr; 36(2 Suppl 1):S42-51. PubMed ID: 19393835
[TBL] [Abstract][Full Text] [Related]
14. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells.
Roninson IB; Broude EV; Chang BD
Drug Resist Updat; 2001 Oct; 4(5):303-13. PubMed ID: 11991684
[TBL] [Abstract][Full Text] [Related]
15. Impaired DNA damage response--an Achilles' heel sensitizing cancer to chemotherapy and radiotherapy.
Darzynkiewicz Z; Traganos F; Wlodkowic D
Eur J Pharmacol; 2009 Dec; 625(1-3):143-50. PubMed ID: 19836377
[TBL] [Abstract][Full Text] [Related]
16. DNA damage response--a double-edged sword in cancer prevention and cancer therapy.
Tian H; Gao Z; Li H; Zhang B; Wang G; Zhang Q; Pei D; Zheng J
Cancer Lett; 2015 Mar; 358(1):8-16. PubMed ID: 25528631
[TBL] [Abstract][Full Text] [Related]
17. Poly(ADP-ribose) polymerase inhibitors in cancer treatment: a clinical perspective.
Sandhu SK; Yap TA; de Bono JS
Eur J Cancer; 2010 Jan; 46(1):9-20. PubMed ID: 19926276
[TBL] [Abstract][Full Text] [Related]
18. The DNA damage response: putting checkpoints in perspective.
Zhou BB; Elledge SJ
Nature; 2000 Nov; 408(6811):433-9. PubMed ID: 11100718
[TBL] [Abstract][Full Text] [Related]
19. Cell Death Response to DNA Damage.
Wang JYJ
Yale J Biol Med; 2019 Dec; 92(4):771-779. PubMed ID: 31866794
[TBL] [Abstract][Full Text] [Related]
20. Targeting DNA repair pathways: a novel approach to reduce cancer therapeutic resistance.
Zhu Y; Hu J; Hu Y; Liu W
Cancer Treat Rev; 2009 Nov; 35(7):590-6. PubMed ID: 19635647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
